Bank Of America Corp Kala Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.25 - $0.36 $5 - $7	-22 Reduced 0.5%	4,410 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.3 - $1.31 $142,654 - $622,925	-475,516 Reduced 99.08%	4,432 $1,000
Q1 2022 May 16, 2022	SELL	$0.61 - $1.84 $18,723 - $56,476	-30,694 Reduced 6.01%	479,948 $662,000
Q4 2021 Feb 08, 2022	BUY	$1.16 - $2.74 $546,182 - $1.29 Million	470,847 Added 1183.18%	510,642 $618,000
Q3 2021 Nov 15, 2021	SELL	$2.62 - $5.43 $180,824 - $374,762	-69,017 Reduced 63.43%	39,795 $104,000

Q2 2021 Sep 13, 2021	BUY	$5.06 - $8.15 $550,588 - $886,817	108,812 New	108,812 $577,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.